On Monday, July 9, 2012, the President signed into law:
H.R. 33, the "Church Plan Investment Clarification Act," which amends the Securities Act of 1933 to provide specifically for an exemption from SEC requirements in connection with church pension plans participating in collective trust funds;
H.R. 2297, which makes technical amendments to the District of Columbia Code to facilitate development of the Southwest Waterfront in the District of Columbia; and
S. 3187, the "Food and Drug Administration Safety and Innovation Act," which reauthorizes a number of FDA user fee programs, including the Prescription Drug User Fee Act and Medical Device User Fee and Modernization Act, and increases FDA's ability to provide timely and expedited review and approval of applications for prescription drugs and medical devices; authorizes new user fee programs for generic drugs and biosimilar biological products; extends and modifies FDA authorities related to drugs intended for use by children; and improves the drug approval process and helps to reduce drug shortages.